Cited In for PMID: 37142533

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2023	1
2025	1
2026	0

2 results

Page of 1

Results by year

Page 1

The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study).

Clavijo LC, Caro J, Choi J, Caro JA, Tun H, Rowe V, Kumar SR, Shavelle DM, Matthews RV. Clavijo LC, et al. Cardiovasc Revasc Med. 2023 Oct;55:1-5. doi: 10.1016/j.carrev.2023.04.020. Epub 2023 Apr 29. Cardiovasc Revasc Med. 2023. PMID: 37142533 Clinical Trial.

Effect of lipid-lowering therapies on flow-mediated dilation in patients: A systematic review and meta-analysis of clinical randomized controlled trials.

Wang X, Zhou L, Wang Q, Wu M. Wang X, et al. PLoS One. 2025 Jun 3;20(6):e0323210. doi: 10.1371/journal.pone.0323210. eCollection 2025. PLoS One. 2025. PMID: 40460064 Free PMC article.

Page of 1

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 37142533

2 results

Results by year